Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
04/2010
04/01/2010US20100081829 Method for producing phenolphthalein using a heteropolyacid catalyst
04/01/2010US20100081828 Catalytic method for producing phenolphthalein compounds
04/01/2010US20100081806 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
04/01/2010DE102008049767A1 N-geschützte Guanidin-substituierte Furane, Thiophene und Pyrrole als Cystein-Protease-Inhibitoren N-protected guanidine-substituted furans, thiophenes and pyrroles as cysteine ​​protease inhibitors
03/2010
03/31/2010EP2168962A2 Phenylacetamides and their use as glucokinase modulators
03/31/2010EP2168956A2 Synthesis of 2-Hydroxy-N,N-Dimethyl-3-[[2-[1(r) - (5-Methyl-2-Furanyl) Propyl] -3, 4-Dioxo-1-Cyclobuten-1-Yl]amino] Benzamide
03/31/2010EP2168955A1 Sleep-improving agent
03/31/2010EP2167482A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases
03/31/2010EP2167466A1 N-phenyl hydrazides as modulators of the ghrelin receptor
03/31/2010EP2167464A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
03/31/2010EP1756054B1 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
03/31/2010EP1252139B1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
03/31/2010CN101687790A Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
03/31/2010CN101687789A Novel inhibitors hepatitis c virus replication
03/31/2010CN101687764A Method for preparing 2-(n-butyl)-5-nitrobenzofuran
03/31/2010CN101687762A Asymmetric bf3 complex
03/31/2010CN101686925A Use of ascorbic acid derivatives for the functionalization of matrices
03/31/2010CN101684111A Method for preparing 3-arylbenzofuran ketone compounds
03/31/2010CN101684084A Tetracycline compounds containing carbamido
03/31/2010CN101684083A Guanidinoalkanoylamino substituted tetracycline derivatives
03/31/2010CN101684080A Tetracycline compounds containing hydrazo
03/31/2010CN100596298C 4-deoxyisopodophyllotoxin derivatives, preparation and medicinal uses thereof
03/31/2010CN100596297C Technology for extracting dihydrogalanthamine from lycoris radiata genus plant
03/30/2010US7687665 2-(4-Chlorophenyl)-N-[(1R,2R)-2-(benzyloxy)cyclohexyl]-2-methylpropanamide; modulators of 11- beta hydroxyl steroid dehydrogenase type 1 and/or mineralocorticoid receptor
03/30/2010US7687664 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it
03/30/2010US7687645 Intermediates for the preparation of citalopram and escitalopram
03/30/2010US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders;
03/30/2010US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders
03/30/2010CA2386807C Method of preparing cox-2 inhibitors
03/30/2010CA2360685C Methods for restoring and/or enhancing accommodation in pseudo phakia
03/25/2010WO2010033593A2 Rosin derived epoxides and curing agents
03/25/2010WO2010032771A1 Amino acid derivative
03/25/2010WO2010032136A1 Expeditious synthesis of gibberllin a5 and esters thereof
03/25/2010WO2010031750A1 Organic compounds for applications in bacterial infections treatment
03/25/2010WO2010006123A3 19-nor-vitamin d analogs with 1,2-dihydrofuran ring
03/25/2010WO2010006121A3 19-nor-vitamin d analogs with 3,2-dihydrofuran ring
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/25/2010US20100075929 9-aminoacyl tetracycline compounds and methods of use thereof
03/25/2010CA2737877A1 Expeditious synthesis of gibberllin a5 and esters thereof
03/25/2010CA2737524A1 Organic compounds for applications in bacterial infections treatment
03/25/2010CA2737431A1 Amino acid derivative
03/24/2010EP2166000A1 7-, 8- and 9-substituted tetracycline compounds
03/24/2010CN101679857A Light-emitting device material and light-emitting device
03/24/2010CN101679337A Anthracene derivative and organic electroluminescent device using the same
03/24/2010CN101679336A Substituted amino-thiourea compounds for combating animal pests
03/24/2010CN101679335A Novel phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome
03/24/2010CN101679247A Process for the manufacture for non-steroidal anti-inflammatory agents and intermediates thereof
03/24/2010CN101676279A Preparation method of zedoary cyclic diolefine
03/24/2010CN101676278A Process for the preparation of tetronic acid
03/24/2010CN101676277A Butyrolactone synthesizing technology
03/24/2010CN101676258A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN100595199C Process for modifying drug crystal formation
03/24/2010CN100595198C Zedoary cyclo-diolefine and its derivatives preparation method and use
03/24/2010CN100595197C Midbody for producing sodium bisulfite andrographolide and production method thereof
03/24/2010CN100595196C Method for synthesizing 4-(1',3'-conjugated diene-2'-base)-2,5-dihydrofuran
03/23/2010US7683202 Permanent surface modifiers
03/23/2010US7683190 Synthesis of 3a,6,6,9a-tetramethyl-dodecahydro-naphtho[2,1-b]furan mixture having greater content of one isomer; esterification of farnesic acid derivative with chiral alcohol, reduction and cyclization; simple, mild conditions
03/23/2010US7683188 Process for preparation of mycophenolic acid and ester derivatives thereof
03/23/2010US7683187 reacting aldehyde with organic halide in carbon chain extension reaction to form alcohol compound comprising functional group capable of allowing for carbonylation of said alcohol compound, then reacting alcohol compound in carbonylation reaction to form hydroxycarboxylic acid, then cyclizing
03/23/2010US7683186 Optically active biaryl phosphorus compound and production process thereof
03/23/2010US7683097 Topoisomerase inhibitors
03/23/2010US7683088 Compounds for the treatment of inflammatory disorders
03/23/2010CA2405972C Process for the preparation of aniline compounds
03/18/2010WO2010030592A1 Compounds for the treatment of hepatitis c
03/18/2010WO2010030026A1 Polyester, polyurethane and methods for producing same
03/18/2010US20100069650 Polynary metal oxide phosphate
03/18/2010US20100069630 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
03/18/2010US20100069484 SIGMA(s)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION
03/18/2010US20100069477 Methioninase inhibitor and composition and food or drink containing the same
03/18/2010US20100069446 L-threonine derivatives of high therapeutic index
03/18/2010US20100068695 Inhibitor for enzyme having two divalent metal ions as active center
03/18/2010US20100068138 Structurally rigid dopamine d3 receptor selective ligands and process for making them
03/18/2010CA2736988A1 Compounds for the treatment of hepatitis c
03/17/2010EP2163550A1 Anthracene derivative and organic electroluminescent device using the same
03/17/2010EP2163549A1 Process for the Preparation of Tetronic Acid
03/17/2010EP2163537A1 Asymmetric bf3 complex
03/17/2010EP1768969B1 Crystalline mycophenolate sodium
03/17/2010EP1685120B1 Colouring hydrosoluble yellow preparation derived from dihydrochalcones
03/17/2010CN101675035A Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
03/17/2010CN101671346A Lindenrane-type dimerization sesquiterpenoids, preparation method and applications thereof in pharmacy
03/17/2010CN101671323A Method for synthesizing 1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ketone
03/17/2010CN101671322A Method for separating and purifying andrograholide
03/17/2010CN101671321A Method for separating and purifying dehydroandrographolide
03/17/2010CN101671320A Method for separating and purifying deoxyandrographolide
03/17/2010CN101671291A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/17/2010CN101671227A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/17/2010CN100594206C Method for extracting protocatechualdehyde and salviol acid from red sage root
03/16/2010US7678926 non-steroidal agonists and antagonists; 2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-1H-benzofuran-5--carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, AIDS, cachexia, as a male contraceptive
03/16/2010US7678904 or to treat autoimmune and inflammatory disorders; improved water solubility characteristics
03/16/2010US7678834 Substituted 4-aminocyclohexanol compounds
03/16/2010US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
03/16/2010US7678829 Oculoselective drugs and prodrugs
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010US7678798 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
03/16/2010US7678776 Inclusion complexes of butylphthalide with cyclodextrin or its derivatives, a process for their preparation and the use thereof
03/16/2010US7678299 Stock solution for production of nonlinear-optical materials, nonlinear-optical material, and nonlinear-optical device
03/11/2010WO2010027594A2 Cinnamic acid-based oligomers and uses thereof
03/11/2010US20100063304 Apparatus for automatic catalyst exchange in a reactor with a bundle of catalyst tubes
03/11/2010US20100063294 Alcohol production method by reducing ester of lactone with hydrogen
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 472